• Home
  • Company
    • Overview
    • Board of Directors
    • Management Team
    • Corporate Governance
    • Contact Us
  • Product Candidates
    • Product Candidates Overview
    • Cardiovascular Diseases
    • Spine Orthopedic Disorders
    • Oncology & Hematology
    • Immune-Mediated & Inflammatory Conditions
    • Clinical Trials
    • Expanded Access Policy
  • Science
    • Mesenchymal Lineage Cells
    • Mechanisms of Action
    • Manufacturing
    • Intellectual Property
    • Scientific Publications
  • Partnerships
    • Overview
  • Investors & Media
    • At A Glance
    • Company Announcements
    • Share Price & Tools
    • Events & Presentations
    • Financial Information
    • Shareholder Services
  • Careers
    • Current Opportunities
Mesoblast
Home Contact Us
  • Home
  • Company
    • Overview
    • Board of Directors
    • Management Team
    • Corporate Governance
    • Contact Us
  • Product Candidates
    • Product Candidates Overview
    • Cardiovascular Diseases
    • Spine Orthopedic Disorders
    • Oncology & Hematology
    • Immune-Mediated & Inflammatory Conditions
    • Clinical Trials
    • Expanded Access Policy
  • Science
    • Mesenchymal Lineage Cells
    • Mechanisms of Action
    • Manufacturing
    • Intellectual Property
    • Scientific Publications
  • Partnerships
    • Overview
  • Investors & Media
    • At A Glance
    • Company Announcements
    • Share Price & Tools
    • Events & Presentations
    • Financial Information
    • Shareholder Services
  • Careers
    • Current Opportunities

Immune and Inflammatory

Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study - E BioMedicine, October 2016

Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study - Diabetes Care, July 2015

Mesenchymal Precursor Cell Therapy for Diabetic Nephropathy: A Phase 2 Randomized Controlled Trial - 75th Scientific Sessions of the American Diabetes Association, June 2015

Effect of Mesenchymal Precursor Cells on the Systemic Inflammatory Response and Endothelial Dysfunction in an Ovine Model of Collagen-Induced Arthritis - PLOS One, May 2015

Treatment of Inflammatory Diseases with Mesenchymal Stem Cells - Inflammation & Allergy, 2009

  • Mesenchymal Lineage Cells
    • Complementary Technologies
  • Mechanisms of Action
  • Manufacturing
  • Intellectual Property
  • Scientific Publications
    • Stem Cell Technology
    • Cardiac and Vascular
    • Orthopedic
    • Immune and Inflammatory
    • Oncology
    • Neurologic
  • Home
  • Company
    • Overview
    • Board of Directors
    • Management Team
    • Corporate Governance
    • Contact Us
  • Product Candidates
    • Product Candidates Overview
    • Cardiovascular Diseases
    • Spine Orthopedic Disorders
    • Oncology & Hematology
    • Immune-Mediated & Inflammatory Conditions
    • Clinical Trials
    • Expanded Access Policy
  • Science
    • Mesenchymal Lineage Cells
    • Mechanisms of Action
    • Manufacturing
    • Intellectual Property
    • Scientific Publications
  • Partnerships
    • Overview
  • Investors & Media
    • At A Glance
    • Company Announcements
    • Share Price & Tools
    • Events & Presentations
    • Financial Information
    • Shareholder Services
  • Careers
    • Current Opportunities
  • Copyright © 2025 Mesoblast Ltd
  • Disclaimer
  • Privacy Policy
  • Search